Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3124 results found
Expand All
Apply All
3124 results found

Advanced/Innovative Manufacturing 101
Share
Human Health, Biotech Basics  •  Toolkit  •  June 27, 2022
Our members are pioneering research into new breakthroughs, but an R&D amortization provision from the '17 Tax Cuts & Jobs Act that just went into effect will negatively impact this work.
Read More

Advanced/Innovative Manufacturing 101
Share
Human Health, Biotech Basics  •  Toolkit  •  June 27, 2022
Learn more about Advanced/Innovative Manufacturing and its importance to biotech development.
Read More

BIO Sends Letter to Senate Ag Committee Supporting Alexis Taylor to Serve as USDA Under Secretary for Trade and Foreign Agricultural Affairs
Share
Agriculture & Environment  •  Letters, Testimony & Comments  •  June 24, 2022
We write to express our support for the nomination of Oregon Department of Agriculture Director Alexis Taylor to serve as the U.S. Department of Agriculture’s Under Secretary for Trade and Foreign Agricultural Affairs. U.S. agricultural producers and global food security will be well served through Director Taylor’s administration of the department’s trade promotion and capacity building programs—she is uniquely qualified for this role.
Read More

Good Day BIO: COVID vaccines prevented 19.8 million deaths in 2021
Share
Good Day BIO Newsletter  •  June 24, 2022
Ending the week on a high note: COVID vaccines prevented nearly 20 million deaths in 2021 alone, says a new study. And from bird flu to stopping salmonella outbreaks, CRISPR technology is improving the health of chickens and the risk to humans. (667 words, 3 minutes, 20 seconds)
Read More

Good Day BIO: PBM transparency bill advances
Share
Good Day BIO Newsletter  •  June 23, 2022
Lots of news today from Capitol Hill on PBMs, ARPA-H, and a new insulin bill—plus, BIO’s comments to OSTP on sustainable chemistry. (725 words, 3 minutes, 37 seconds)
Read More

BIO Comments on FDA Quality Metrics Reporting Program
Share
Letters, Testimony & Comments  •  June 22, 2022
On Wednesday, June 22nd, BIO submitted comments on the FDA’s Quality Metrics (QM) Reporting Program. In the comments submitted, BIO stated appreciation for FDA’s intent to support a general shift toward a risk-based approach to regulation by bolstering its quality surveillance activities. However, BIO expressed the need for clarification around the program’s implementation to ensure it meets the Agency’s objectives without resulting in unintended consequences for both sponsors and regulators. In general, BIO pointed out significant variability in how metrics would be identified, defined, and reported. In addition to challenges posed by this variability, it is unclear how such data would be utilized by FDA. Thus, required reporting of lower-level metrics without contextual information associated with the data or trends could negatively impact sponsor operations and increase the potential for regulatory misinterpretation.
Read More

Good Day BIO: M&As can help patients – and bird flu's on the rise
Share
Good Day BIO Newsletter  •  June 22, 2022
A small biotech tells the FTC how M&As can help advance innovation for patients—and a rise in bird flu, including in the U.S., tells us that it’s time to advance gene editing and One Health. (591 words, 2 minutes, 57 seconds)
Read More

Leveraging V3 for Digitally Derived Endpoints Framework - V3 as Applied to DHTTs Used in Various Drug Development Scenarios
Share
Human Health, Biotech Basics  •  Toolkit  •  June 22, 2022
Leveraging V3 for Digitally Derived Endpoints Framework - V3 as Applied to DHTTs Used in Various Drug Development Scenarios
Read More

Good Day BIO: We don't need a vaccine IP waiver – here's why
Share
Good Day BIO Newsletter  •  June 21, 2022
Back to work—and we take a deeper dive into why we don’t need the COVID vaccine waiver. Meanwhile, extreme heat is killing cows in Kansas—but the FDA’s already given the green light to a biotech solution for cattle welfare. (695 words, 3 minutes, 28 seconds)
Read More

Good Day BIO: TRIPS waiver news – plus, Juneteenth and World Sickle Cell Day
Share
Good Day BIO Newsletter  •  June 20, 2022
On Friday, the WTO agreed to a waiver of COVID vaccine intellectual property protections—here’s what we know. And while it’s a federal holiday in DC (and for BIO) for Juneteenth, we want to take a moment to look at why this day is an important reminder of the need for diversity, equity, and inclusion in health care and our industry. (733 words, 3 minutes, 39 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 137
  • 138
  • 139
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO